Ken Griffin Intercure Ltd. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Intercure Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,900 shares of INCR stock, worth $3,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,900
Previous 5,600
48.21%
Holding current value
$3,393
Previous $11,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INCR
# of Institutions
25Shares Held
3.44MCall Options Held
19.5KPut Options Held
100-
Ibex Investors LLC1.89MShares$2.21 Million9.38% of portfolio
-
ETF Managers Group, LLC Summit, NJ811KShares$949,2010.06% of portfolio
-
Toroso Investments, LLC Massapequa, NY230KShares$268,5150.01% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6213KShares$248,6240.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD107KShares$125,6740.04% of portfolio
About Intercure Ltd.
- Ticker INCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,133,900
- Market Cap $52.8M
- Description
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...